Quantcast
Last updated on April 17, 2014 at 21:23 EDT
Silly Putty Ingredient Could Help Stem Cells Become Motor

Silly Putty Ingredient Could Help Stem Cells Become Motor Neurons

redOrbit Staff & Wire Reports - Your Universe Online An ingredient found in Silly Putty could help scientists more efficiently turn human embryonic stem cells into fully functional specialized cells, according to research published online...

Latest Stem cell treatments Stories

2014-04-16 11:43:12

UC Irvine neurobiologists have found that genetically modified neural stem cells show positive results when transplanted into the brains of mice with the symptoms and pathology of Alzheimer's disease. The pre-clinical trial is published in the journal Stem Cells Research and Therapy, and the approach has been shown to work in two different mouse models. Alzheimer's disease, one of the most common forms of dementia, is associated with accumulation of the protein amyloid-beta in the brain in...

2014-04-16 08:34:35

NSI-566 to be Tested in Patients with Chronic Spinal Cord Injury ROCKVILLE, Md., April 16, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that the Institutional Review Board of the University of California, San Diego, School of Medicine has approved the Phase I safety trial to treat chronic spinal cord injury (cSCI) with its NSI-566 stem cells. The NSI-566/cSCI Phase I trial will enroll patients with thoracic spinal cord injuries (T2-T12) who have an American Spinal...

2014-04-15 12:30:19

Dr. James Andrews, Respected Orthopedic Surgeon and Founding Member of American Sports Medicine Institute, To Serve as Principal Investigator BURLINGTON, Mass., April 15, 2014 /PRNewswire/ -- inVentiv Health Clinical, a leading global supplier of drug development services, announced today that it has been selected for an osteoarthritis Investigational New Drug Application (IND) by the innovative regenerative medicine biotechnology company IntelliCell BioSciences, Inc.,...

2014-04-15 08:30:55

SAN BRUNO, Calif., April 15, 2014 /PRNewswire/ -- Cord Blood Registry® (CBR®) announces the launch of an FDA-regulated clinical trial being conducted at The University of Texas Health Science Center at Houston to investigate two forms of stem cell therapy in children diagnosed with cerebral palsy. The randomized, placebo-controlled study aims to compare the safety and efficacy of an intravenous infusion of cord blood stem cells to bone marrow stem cells....

2014-04-09 23:01:31

Join the Irvine Stem Cell Treatment Center for a public seminar on the use of adipose derived stem cells for various degenerative and inflammatory conditions. Irvine, California (PRWEB) April 09, 2014 The Irvine Stem Cell Treatment Center, located in Irvine, California, announces a free public seminar on the use of stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief. The seminar will be held on April 13. On April...

2014-04-08 16:22:59

BEVERLY HILLS, Calif., April 8, 2014 /PRNewswire/ -- Life Stem Genetics, Inc. (LIFS), an emerging company in the advancement of adult stem cell therapies, today announced the appointments of Dr. Roberto Fernandez Vina, Dr. Ranbir Singh Gill, and Dr. Praveen Gill to its Medical Advisory Board. Dr. Roberto Fernandez Vina Born and educated in Argentina, Dr. Roberto Fernandez Vina, MD Cardiology, is a pioneer in the development of multiple adult stem cell therapies, protocols, and...

2014-04-07 08:32:26

Will Also Present Update on Ongoing Phase II Trial ROCKVILLE, Md., April 7, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Eva Feldman, PhD, MD, principal investigator of Neuralstem's NSI-566 stem cell trial in ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease) will present Phase I data at the Keystone Symposia, "Engineering Cell Fate and Function," in Olympic Valley, California, on April 9(th...

2014-04-04 23:41:39

Dr. Jeffrey Adler of Adler Footcare New York will discuss stem cell replacement therapy, a new treatment option available to treat painful foot problems, on NewsTalkRadio 77 WABC in New York City on April 5. New York, New York (PRWEB) April 03, 2014 Dr. Jeffrey Adler, New York podiatrist and Owner/Medical Director of Adler Footcare New York, will be interviewed by radio personality Laura Smith and taking live calls on New York talk show 77 WABC about the use of stem cells to treat...

2014-04-02 11:30:25

Animal study points to promise of gene therapy for treating spinal cord injury Delivering a single injection of a scar-busting gene therapy to the spinal cord of rats following injury promotes the survival of nerve cells and improves hind limb function within weeks, according to a study published April 2 in The Journal of Neuroscience. The findings suggest that, with more confirming research in animals and humans, gene therapy may hold the potential to one day treat people with spinal cord...

2014-04-01 15:21:02

Researchers report they can generate human motor neurons from stem cells much more quickly and efficiently than previous methods allowed. The finding, described in Nature Communications, will aid efforts to model human motor neuron development, and to understand and treat spinal cord injuries and motor neuron diseases such as amyotrophic lateral sclerosis (ALS). The new method involves adding critical signaling molecules to precursor cells a few days earlier than previous methods...